Downregulation of HtrA1 protein is associated with poor survival in mesothelioma [52], hepatocellular carcinoma [53], and breast cancer [54]; in the latter study, nodepositivity was associated with shorter survival. The gene discussed is HTRA1; the disease is breast carcinoma.